The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Waist Circumference, Visceral Obesity, and Cardiovascular Risk
Abstract
Populations of industrialized countries are becoming more overweight as a result of deleterious changes in lifestyle, and obesity is expected to become the most common health problem of the 21st century.1 Obesity is associated with an increased risk of morbidity and mortality, and with reduced life expectancy.2-4 Moreover, obesity is becoming the major driving force responsible for the increased prevalence of cardiovascular disease (CVD) in the developed world. This chronic noncommunicable disease is therefore a major contributor to the global burden of disease and disability associated with numerous conditions such as coronary artery disease (CAD), stroke, hypertension, dyslipidemia, type 2 diabetes mellitus, osteoarthritis, pulmonary embolism, respiratory abnormalities and sleep apnea.1,5 Yet only recently has obesity been given the same level of attention as other risk factors for CAD5 and recognized as largely responsible for the prevalence of diseases worldwide in the near future6 (Table 1). Accordingly, the American Heart Association has stated that obesity is a major modifiable risk factor for heart disease.7,8 This review discusses the importance of visceral obesity as a health risk from a cardiovascular prevention and cardiac rehabilitation perspective.Table 1: • THE WORLDWIDE 5 LEADING CAUSES OF DISEASE BURDEN MEASURED IN DISABILITY ADJUSTED LIFE YEARS FOR THE PERIOD 1990 TO 2020EPIDEMIOLOGY The prevalence of obesity in the United States has increased steadily over the past 40 years.9 In industrialized countries, this scourge has reached epidemic proportions.10-13 For instance, within the past 10 years, the percentage of overweight and obese individuals in North America and in some countries in Europe has increased to more than 50% of adults age 20 years or older.9,11 Accordingly, among the 9405 patients evaluated at the Duke University cardiac catheterization laboratory, the prevalence of obesity has increased from 20% to 33% in only 10 years (1986 to 1997).14 In the catheterization laboratory, obesity was associated with younger age and more comorbidities, but with singlevessel disease at baseline.14-16 Obesity also was associated with more clinical events over the 30-day period after cardiac catheterization, with higher cumulative inpatient medical costs and significant differences in unadjusted survival at 10 years.14 It also has been reported that overweight and obese patients are highly prevalent (88%) in cardiac rehabilitation programs.17 Therefore, although some studies have questioned the contribution of obesity to clinical outcomes among patients undergoing angiography,15,16 the recognition of obesity as a health problem is critical in the context of a cardiac prevention and rehabilitation program aimed at preventing a first or recurrent CAD event. DEFINITION OF OBESITY According to national and international guidelines, an overweight condition is defined as a body mass index (BMI: weight in kilograms divided by the square of the height in meters) of 25 to 29.9 kg/m2, and obesity is defined as a BMI of 30 kg/m2 or more.10 On that basis, all overweight and obese adults older than 18 years with a BMI of 25 kg/m2 or more are assumed to be at risk for the development of cardiovascular co-morbidities.1 However, BMI does not account for the wide variation in body fat distribution, does not address the etiologic factors leading to obesity across different individuals and populations, and does not relate body composition and body size to health outcomes. Although obesity per se is considered a major modifiable risk factor for ischemic heart disease,7,8 it is of clinical importance to keep in mind that a remarkable heterogeneity exists among obese subjects, and that the presence of visceral obesity generally worsens the “metabolic portrait,” which is associated with a cluster of traditional and nontraditional risk factors: an atherogenic dyslipidemic state, hypertension, insulin resistance and hyperinsulinemia, type 2 diabetes mellitus, and a prothrombotic and inflammatory state. These abnormalities all are potentially synergistic and deleterious in increasing congestive heart disease (CHD) risk.5,18 Thus, an abundant literature published over the past 20 years has emphasized that abdominal obesity is more important than excess fat as a correlate of the complications previously regarded as the consequence of obesity per se.19-22 Because not all obese individuals are at increased risk of CVD, the challenge for the clinician in preventive cardiology is to identify the subgroup of obese patients who are “at risk” for CVD (ie, obese patients characterized by the atherogenic cluster of metabolic abnormalities referred to as the “metabolic syndrome”). In addition to its well-documented role in lipid storage and mobilization, adipose tissue is a major site of cytokine production, which also may play a role in the atherosclerotic process, increasing the risk of an acute coronary syndrome. Figure 1 presen
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687
Effects of the amount and intensity of exercise on plasma lipoproteins
Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554
Ross, R., Dagnone, D., Jones, P. J. H., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00008 · Cited by 1,435
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Self-citationThe Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Self-citationFox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“estingly, not every obese patient is hypertensive, indicating again the heterogeneity of obesity from the vascular standpoint (437).”
BackgroundSelf-citation
Metadata
- Authors
- Poirier, P., & Després, J.-P.
- Venue
- Journal of Cardiopulmonary Rehabilitation
- Published
- 2003-05
- Volume
- 23
- Issue
- 3
- Pages
- 161-169
- ISSN
- 0883-9212 (ISSN-L)
- OpenAlex
- W1971786913
- Cited by
- 158
- References
- 27
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Waist Circumference, Visceral Obesity, and Cardiovascular Risk. https://app.cochat.ai/papers/10.1097/00008483-200305000-00001
- The paper
- Poirier, P., & Després, J.-P. (2003). Waist Circumference, Visceral Obesity, and Cardiovascular Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200305000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.